Economic Conditions: Economic growth or recession in Indonesia can significantly impact PRAS.JK as it affects consumer spending and overall market sentiment.

Company Performance: PRAS.JK's revenue, profitability, and growth prospects directly influence investor confidence and stock price.

Industry Trends: Changes in the pharmaceutical industry, including new regulations, technological advancements, and competitor activities, affect PRAS.JK's market position and stock valuation.

Investor Sentiment: General market optimism or pessimism, often driven by news events or global economic factors, can lead to buying or selling pressure on PRAS.JK shares.

Government Policies: Healthcare policies, drug pricing regulations, and import/export policies in Indonesia can have a direct impact on PRAS.JK's operations and financial performance.

Interest Rates: Changes in interest rates set by Bank Indonesia can affect borrowing costs for PRAS.JK and influence investment decisions in the stock market.

Currency Fluctuations: The Indonesian Rupiah's exchange rate against other currencies can impact PRAS.JK's import costs (raw materials) and export revenues, thereby affecting profitability.

Global Events: International events like pandemics, geopolitical tensions, or global economic crises can trigger volatility in the Indonesian stock market, impacting PRAS.JK's price.

Dividend Policy: PRAS.JK's dividend payouts and dividend yield can attract or deter investors, affecting demand for the stock and its price.

Regulatory Changes: Changes in regulations related to pharmaceutical manufacturing, distribution, or sales can impact PRAS.JK's operations and profitability.